证券记录 · 已归档季度
DNTH
Dianthus Therapeutics, Inc. · Healthcare · Biotechnology
11被追踪持有人
+1Δ持有人
11.18M持有股份
$208.23M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 +3.0% ·
净新建仓位 +9.1%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 96 | +12 | 36.60M | $3.56B | +16 | −4 |
| Q1 2026 | 87 | +18 | 31.37M | $2.59B | +21 | −3 |
| Q4 2025 | 69 | +2 | 26.03M | $1.07B | +3 | −1 |
| Q3 2025 | 16 | +2 | 17.27M | $679.58M | +2 | — |
| Q2 2025 | 11 | +1 | 11.18M | $208.23M | +1 | — |
| Q1 2025 | 7 | -2 | 3.50M | $63.53M | — | −2 |
| Q4 2024 | 9 | -1 | 2.27M | $49.52M | +1 | −2 |
| Q3 2024 | 9 | +3 | 1.20M | $32.83M | +4 | −1 |
| Q2 2024 | 6 | — | 1.13M | $29.26M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 4.54M | — | $84.66M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 4.54M | — | $84.66M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 4.54M | — | $84.66M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 1.45M | — | $26.94M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (被动) | 1.45M | — | $26.94M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (被动) | 1.45M | — | $26.94M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 1.39M | -6.3% | $25.94M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 1.36M | — | $25.31M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 1.36M | — | $25.31M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 1.36M | — | $25.31M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 1.36M | — | $25.31M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 1.36M | — | $25.31M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 1.36M | — | $25.31M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 1.36M | — | $25.31M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (被动) | 820.14K | +8.0% | $15.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 665.04K | +41.2% | $12.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 665.04K | +41.2% | $12.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Geode Capital Management ✦ (被动) | 484.90K | -6.2% | $9.04M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Geode Capital Management ✦ (被动) | 484.90K | -6.2% | $9.04M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Millennium Management ✦ | 195.36K | 新增 | $3.64M | 0.0% | New | 1 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 185.00K | -2.1% | $3.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 74.35K | +9.4% | $1.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | Wellington Management ✦ | 74.35K | +9.4% | $1.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | Wellington Management ✦ | 74.35K | +9.4% | $1.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | T. Rowe Price ✦ | 10.69K | +1.9% | $200,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $3.64M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 240 持有人, 62.10M 股份, $4.94B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Read Simon
Director · 2.78K 股 · $326,554
Aug 10
Read Simon
Director · 737 股 · $79,721
Aug 10
Read Simon
Director · 831 股 · $90,537
Aug 10
Read Simon
Director · 272 股 · $29,909
Aug 10
Read Simon
Director · 470 股 · $52,194
Aug 10
Read Simon
Director · 397 股 · $44,373
Aug 10
McGeorge Anne
Director · 700 股 · $77,987
Aug 10
Read Simon
Director · 70 股 · $7,498
Aug 10
McGeorge Anne
Director · 2.80K 股 · $303,464
Aug 10
McGeorge Anne
Director · 1.80K 股 · $196,740
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A — Sirenia Capital Management LP
Aug 13
SC 13G — WELLINGTON MANAGEMENT GROUP LLP
Aug 07
SC 13G/A — T. Rowe Price Investment Management…
Aug 07
SC 13G — T. Rowe Price Investment Management…
Jul 28
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据